Kyoichiro Kobayashi
Kyoto Prefectural University of Medicine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kyoichiro Kobayashi.
Atherosclerosis | 1996
Toshiyuki Tamagaki; Shohei Sawada; Hitoshi Imamura; Y. Tada; Seiki Yamasaki; Akihisa Toratani; Toshiyuki Sato; Sumio Komatsu; Naoaki Akamatsu; Mashahito Yamagami; Kyoichiro Kobayashi; Kazuharu Kato; Katsumi Yamamoto; Kaoru Shirai; Keizo Yamada; Tadashi Higaki; Katsumi Nakagawa; Hajime Tsuji; Masao Nakagawa
We investigated the effects of high-density lipoprotein (HDL) on the intracellular pH ([pH]i), and on the proliferation of human vascular endothelial cells (HUVEC), as well as on their production of prostacyclin (PGI2). The [pH]i was slightly acidified when extracellular Ca2+ was chelated with EGTA. Pretreatment of HUVEC with amiloride, the Na+/H+ exchange inhibitor, caused the [pH]i to become strongly acidic. The addition of HDL produced a biphasic shift in [pH]i, with a brief initial acidification followed by a rapid alkaline shift. The initial decrease in [pH]i was abolished in the cells pretreated with EGTA, and subsequent alkalinization was inhibited. The alkalinization of [pH]i disappeared in the cells pretreated with amiloride. These results suggest that [pH]i depends mainly on Na+/H+ exchange and partially on the extracellular Ca2+ of the HUVEC either in the resting unstimulated state or during HDL stimulation. In contrast, the addition of LDL produced an acidification of [pH]i, which was increased by LDL in the Ca(2+)-free condition. In the cells pretreated with amiloride, [pH]i was not further acidified by LDL. As a result, HDL promoted the proliferation of cells, an action that was inhibited by pretreatment with EGTA. However LDL inhibited cell proliferation, an action unaffected by EGTA pretreatment. The addition of HDL also enhanced the generation of prostacyclin in endothelial cells, the enhancement of PGI2 generation resulted from an increase in the release of Ca2+ from storage sites, due not only to an increased production of inositol 1,4,5-trisphosphate (IP3), but also to the alkalinization of [pH]i. These effects may be involved in the mechanism of HDLs anti-atherosclerotic action.
Archive | 1993
Masahito Yamagami; Shohei Sawada; Toshiyuki Tamagaki; Kyoichiro Kobayashi; Kazuharu Kato; Katsumi Yamamoto; Kaoru Shirai; Keizo Yamada; Haruchika Masuda; Katsumi Nakagawa; Hajime Tsuji; Masao Nakagawa
Among the many events that occur in stimulated cells, there is always a significant shift in intracellular pH ([pH]i). The expression of some cellular responses after stimulation have been attributed to this pH shift. In neutrophils, stimulus-induced alkaline shifts in [pH]i have been proposed to modulate chemotaxis, aggregation, phagocytosis, secretion and the generation of superoxide radicals1)–3). In recent years, a convincing role for changes in [pH]i in the action of extracellular growth stimulation has been documented with a variety of cell types in culture4). However, the relationship between [pH], and the antithrombotic mechanisms of vascular endothelial cells has not been investigated. In the present study, the effects of [pH], on the antithrombotic properties of vascular endothelial cells were investigated utilizing human umbilical vein endothelial cells (HUVEC).
Archive | 1993
Katsumi Nakagawa; Hajime Tsuji; Keizo Yamada; Mitsuru Yoneda; Osamu Takada; Yuka Yamada; Haruchika Masuda; Masashi Uno; Toshiyuki Tamagaki; Masahito Yamagami; Kazuharu Katoh; Katsumi Yamamoto; Kyoichiro Kobayashi; Shohei Sawada; Masao Nakagawa
Tissue plasminogen activator (t-PA) is being used as thrombolytic therapy for patients with acute myocardial infarction [1], given in combination with anticoagulants such as heparin or warfarin. We compared the effects of the new selective thrombin inhibitors, argatroban and hirudin, with those of heparin, on the thrombolysis mediated by t-PA in an experimental model of thrombosis using the hamster cheek pouch.
Japanese Circulation Journal-english Edition | 1992
Kazuharu Kato; Shohei Sawada; Takeo Toyoda; Kyoichiro Kobayashi; Kaoru Shirai; Katsumi Yamamoto; Toshiyuki Tamagaki; Masahito Yamagami; Mitsuru Yoneda; Osamu Takada; Masashi Uno; Hajime Tsuji; Masao Nakagawa
Japanese Circulation Journal-english Edition | 1989
Masashi Uno; Hajime Tsuji; Masahiko Watanabe; Osamu Takada; Kyoichiro Kobayashi; Hiroaki Takabuchi; Kaori Shirai; Shohei Sawada; Takeo Toyoda; Katsumi Yamamoto; Kazuharu Katoh; Masao Nakagawa
Japanese Journal of Thrombosis and Hemostasis | 1992
Hiroaki Takabuchi; Hajime Tsuji; Mitsuru Yoneda; Osamu Takada; Masahiko Watanabe; Masashi Uno; Kazuharu Kato; Katsumi Yamamoto; Kyoichiro Kobayashi; Shohei Sawada; Masao Nakagawa
Japanese Journal of Thrombosis and Hemostasis | 1993
Osamu Takada; Hajime Tsuji; Mitsuru Yoneda; Katsumi Nakagawa; Hiroshi Masuda; Keizo Yamada; Yuka Yamada; Masahiko Watanabe; Katsumi Yamamoto; Kazuharu Kato; Kyoichiro Kobayashi; Syohei Sawada; Masao Nakagawa
Japanese Journal of Thrombosis and Hemostasis | 1990
Katsumi Yamamoto; Takeo Toyoda; Shohei Sawada; Kaoru Shirai; Kyoichiro Kobayashi; Kazuharu Katoh; Osamu Takada; Masahiko Watanabe; Masashi Uno; Hajime Tsuji; Masao Nakagawa
Japanese Journal of Thrombosis and Hemostasis | 1992
Masahito Yamagami; Shohei Sawada; Toshiyuki Tamagaki; Katsumi Yamamoto; Kazuharu Kato; Kyoichiro Kobayashi; Kaoru Shirai; Takeo Toyoda; Katsumi Nakagawa; Haruchika Masuda; Keizo Yamada; Yuka Miyashita; Mitsuru Yoneda; Osamu Takada; Hajime Tsuji; Masao Nakagawa
The journal of Japan Atherosclerosis Society | 1990
Kazuharu Kato; Takeo Toyoda; Shohei Sawada; Kaoru Shirai; Kyoichiro Kobayashi; Katsumi Yamamoto; Osamu Takada; Masahiko Watanabe; Hiroaki Takabuchi; Masashi Uno; Hajime Tsuji; Masao Nakagawa